We are live on ! Find out more
BIAFW icon

bioAffinity Technologies
BIAFW

4 hedge funds and large institutions have $226K invested in bioAffinity Technologies in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

829% more capital invested

Capital invested by funds: $24.3K → $226K (+$201K)

0.19% more ownership

Funds ownership: 3% → 3.19% (+0.19%)

0% more funds holding

Funds holding: 4 → 4 (0)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$8.35K

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$2.41K
2
Citadel Advisors
Citadel Advisors
Florida
-$67
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$156K – – –
CS
2
Clear Street
New York
$38.7K +$8.35K +25,112 +99%
Citadel Advisors
3
Citadel Advisors
Florida
$18.9K -$67 -201 -0.8%
WAM
4
Warberg Asset Management
Illinois
$12K -$2.41K -7,247 -32%

BIAFW Hedge Fund Activity: Q1 2024 in Review

4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q1 2024, worth a combined $226K — up 829% from $24.3K a quarter earlier.

Fund positioning in BIAFW was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Clear Street, adding an estimated $8.35K. The largest seller was Warberg Asset Management, cutting an estimated $2.41K.

  • 4 institutional investors held bioAffinity Technologies (BIAFW) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $226K of bioAffinity Technologies stock for Q1 2024, up 829% quarter-over-quarter.
  • 0 funds opened new bioAffinity Technologies positions in Q1 2024 and 0 closed out.
  • The largest bioAffinity Technologies buyer in Q1 2024 was Clear Street, an estimated $8.35K added.
  • The largest bioAffinity Technologies seller in Q1 2024 was Warberg Asset Management, an estimated $2.41K sold.

Based on aggregated 13F filings for Q1 2024.